WCN23-0466 PHASE 1 STUDY IN HEALTHY ADULTS OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ALPN-303, A DUAL BAFF/APRIL ANTAGONIST FOR THE TREATMENT OF AUTOIMMUNE GLOMERULONEPHRITIDES

Autor: S.R. Dillon, R. Davies, J.D. Lickliter, K. McLendon, K.L. Manjarrez, A. Smith, M.C. Lessig, L. Blanchfield, R.J. Sanderson, A.G. Chunyk, A. Enstrom, T. Blair, H.Z. Hany Zayed, J. LI, S.L. Peng
Rok vydání: 2023
Předmět:
Zdroj: Kidney International Reports. 8:S68
ISSN: 2468-0249
DOI: 10.1016/j.ekir.2023.02.151
Databáze: OpenAIRE